Research on one of the deadliest malignancies is yielding potentially game-changing insights — and treatments.
Nature Outlook |
Brain cancer is one of the most aggressive and difficult-to-treat malignancies. Moreover, in the almost 50 years since the start of the war on cancer, the prospects for people who develop brain cancer have improved much more slowly than those of individuals with other types of cancer. Despite a lack of progress in the clinic, research on this group of conditions is advancing steadily, and treatments with the potential to transform the field are on the horizon.
This Nature Outlook is editorially independent. It is produced with third party financial support. About this content.
Brain cancer comprises only 2% of cancers, but is notoriously difficult to treat. Understanding the location of such tumours, as well as the underlying genetics, will help to tackle this devastating disease.
Could the latest immunotherapies succeed in tackling the deadliest form of brain cancer?
Neurological symptoms, as well as biological changes in cells and tissues, contribute to the disease’s characteristics, says Terri S. Armstrong.
Before they can get to work, treatments for brain cancer must bypass a formidable obstacle — the blood–brain barrier.
Introduction to brain cancer research at Novocure
To find better treatments for brain cancer, an important step might be to grow mini-brains in the lab.
Other than ionizing radiation and genetics, little is known about the factors that influence a person’s chances of developing the disease.
Computer simulations of tumours could help doctors to choose the most effective approach to treatment.
A flood of sequencing data is enabling researchers to uncover how tumours differ from each other, and what such variation means for treatment strategies.
Brain tumours in children differ fundamentally from those in adults — a discovery with enormous implications for treatment strategies.
From lasers to electrical fields, clinicians are venturing off the beaten path to outflank a formidable foe.
At Novocure, we are very proud of our ongoing commitment and dedication to improving the lives of people with brain cancer. Our patients, their families and caregivers are at the heart of everything we do. They are the people who drive us forward to achieve our goal of delivering a cancer therapy that can extend and maintain the quality of many patients’ lives. We invited one of our many glioblastoma patients to tell us about his own journey from diagnosis to treatment with TTFields. In his own words, the following inspirational story was provided by Brian Biggs of his own experience of living with this devastating disease.